Skip to content

Family Meetings in Memory Clinics: Indicated Prevention of developing Anxiety and Depressive Disorders in primary informal caregivers of demented patients

Family Meetings in Memory Clinics: Indicated Prevention of developing Anxiety and Depressive Disorders in primary informal caregivers of demented patients - FAME

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33647
Enrollment
224
Registered
2007-08-08
Start date
2007-09-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychische stoornissen: angststoornissen- en symptomen anxiety and depressive disorders

Interventions

Four meetings with family and close friends will be organized and run by a trained counsellor according to a manual (Mittelman 2003) . The aim is to offer psycho-education, increase problem-solving

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - family caregiver takes primary responsibility for the informal care of a patient with a clinical diagnosis of dementia and lives in the same region as the patient. - In each family, at least one other family member lives in the same region of the patient and caregiver. - Both caregiver and patient have sufficient language proficiency in Dutch for adequate participation in meetings, interviews and tests. - Written informed consent from both patient and caregiver is obtained. In case of mental incompetence of a patient the family caregiver will sign the consent for the patient.

Exclusion criteria

Exclusion criteria: 1) Severe somatic or psychiatric co-morbidity of either caregiver or patient, which will significantly impair cooperation to the program. 2) Caregiver does have a depressive or anxiety disorder at baseline 3) Either caregiver or patient participates in other intervention studies at inclusion or during the study. 4) Scheduled to move a patient to a nursing home.

Design outcomes

Primary

MeasureTime frame
- Incidence of major depression and anxiety disorders (i.e. generalised anxiety and panic) as defined according to DSM-IV criteria (APA 1994) and assessed with the Mini International Neuropsychiatric Interview (MINI) (Sheehan 1998). The MINI is used as 6 month prevalence measure. - The dimensional or severity measure of anxiety and depression symptoms is derived by validated self report instruments: the Centre for Epidemiologic Studies Depression Scale (CES-D) and Geriatric Depression Scale (GDS-5) for depression, the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS) for anxiety.

Secondary

MeasureTime frame
Caregiver - Caregiver Burden with the Caregiver Reaction Assessment (CRA) (Given 1992) - Sense of competence with the SSCQ (Vernooij-Dassen 2000) - Quality of Life with the Short Form 12 item version (Ware 1995) - 'Quality adjusted life years' with the SF6D (SF-12) Patienten - Depressive symptoms in patients (NPI) - Quality of Life (SF-12) Other - Time until institutionalization - Costs Resource utilization of patient and carer will be measured from a societal perspective with cost diaries (filled out by the carer) which include both direct (hospital visits) and indirect costs (travel time) and both within and outside (loss labour days) the health care (RUD, Wimo 1997)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)